Published in Obesity and Diabetes Week, October 3rd, 2005
The study shows the significantly better performance of the amlodipine and Coversyl (perindopril) treatment strategy versus a beta-blocker/diuretic combination in reducing the risk of mortality, stroke, new-onset diabetes, and coronary events.
In a typical Western country with a population of 50 million people, about eight million receive treatment for high blood pressure; beta-blockers and diuretics are among the treatments most frequently prescribed. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.